Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
https://doi.org/10.20996/1819-6446-2020-02-01
Abstract
The one of the main aims in modern clinical pharmacology is to provide safe and effective therapy considering a frequent administration of several drugs having different drug-drug interactions. Warfarin belongs to the number of popular anticoagulants which along with its efficiency not infrequently alters anticoagulant characteristics when administered with other drugs and food products. A case of a decrease in the efficacy of warfarin in a patient with mitral stenosis while taking a combined choleretic drug is presented in the article. The components of this choleretic drug (dry animal bile, dry garlic extract, dry nettle extract, activated charcoal) could impair the absorption of warfarin, increase intestinal absorption of vitamin K, and have a negative effect on the anticoagulant effect of warfarin. Management of patients receiving anticoagulants should be performed in accordance with clinical recommendations. Prescription of drugs, including multicomponent ones, without proven efficacy, for such patients should be considering the potential drug interaction.
About the Authors
N. T. Vatutin
Donetsk National Medical University named after M. Gorky;
Institute of Urgent and Reconstructive Surgery named after V.K. Gusak
Ukraine
Ukraine
Nikolay T. Vatutin – MD, PhD, Professor, Head of Chair of Hospital Therapy, Donetsk National Medical University named after M. Gorky; Head of Division of Cardiac Surgery and Urgent Cardiology, Institute of Urgent and Reconstructive Surgery named after V.K. Gusak
Ilyicha pr. 16, Donetsk, 83000 Donetsk People Republic/Ukraine;
Leninskij pr. 47, Donetsk, 83000 Donetsk People Republic/ Ukraine
G. G. Taradin
Donetsk National Medical University named after M. Gorky;
Institute of Urgent and Reconstructive Surgery named after V.K. Gusak
Ukraine
Ukraine
Gennadiy G. Taradin – MD, PhD, Associate Professor, Chair of Hospital Therapy, Donetsk National Medical University named after M. Gorky; Senior Researcher, Division of Cardiac Surgery and Urgent Cardiology, Institute of Urgent and Reconstructive Surgery named after V.K. Gusak
Ilyicha pr. 16, Donetsk, 83000 Donetsk People Republic/Ukraine;
Leninskij pr. 47, Donetsk, 83000 Donetsk People Republic/ Ukraine
G. A. Ignatenko
Donetsk National Medical University named after M. Gorky
Ukraine
Ukraine
Grigorij A. Ignatenko – MD, PhD, Professor, Corresponding Member of National Academy of Medical Sciences of Ukraine, Head of Chair of Propaedeutic and Internal Medicine, Rector of Donetsk National Medical University named after M. Gorky
Ilyicha pr. 16, Donetsk, 83000 Donetsk People Republic/Ukraine
E. S. Gasendich
Donetsk National Medical University named after M. Gorky
Ukraine
Ukraine
Ekaterina S. Gasendich – MD, Assistant, Chair of Hospital Therapy
Ilyicha pr. 16, Donetsk, 83000 Donetsk People Republic/Ukraine
A. V. Harchenko
Donetsk National Medical University named after M. Gorky
Ukraine
Ukraine
Anastasija V. Harchenko – MD, Assistant, Chair of Hospital Therapy
Ilyicha pr. 16, Donetsk, 83000 Donetsk People Republic/Ukraine
I. B. Povaljaeva
Institute of Urgent and Reconstructive Surgery named after V.K. Gusak
Ukraine
Ukraine
Irina B. Povaljaeva – MD, Doctor, Department of Functional Diagnostics
Leninskij pr. 47, Donetsk, 83000 Donetsk People Republic/ Ukraine
References
1. Maneshina O.A., Belousov J.B. Polypharmacy and drug interactions in the elderly patients. Kachestvennaya Klinicheskaya Praktika. 2008;(3):90-3 (In Russ.).
2. Hanlon J., Schmader K., Koronkowski M., et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45(8):945-8. DOI:10.1111/j.1532-5415.1997.tb02964.x.
3. Otdelenov V.A., Novakova A.I., Karasev A.V., et al. Estimation of the incidence of potentially significant drug-drug interactions in patients with polypharmacy in the general hospital. Clinical Pharmacology and Therapy. 2012;21(5):81-5 (In Russ.).
4. Lazebnik L.B., Konev J.V., Drozdov V.N., Efremov L.I. Polypharmacy: the geriatric aspect of the problem. Consilium Medicum. 2007;12:29-34 (In Russ.).
5. Vatutin M.T., Gasendich E.S., Iofe E.I. Case of acquired coagulopathy. The Russian Archives of Internal Medicine. 2018;8(6):480-2 (In Russ.). DOI:10.20514/2226-6704-2018-8-6-480-482.
6. Dzemeshkevich S.L. Panchenko E.P. Anticoagulant therapy in patients with cardiac valve abnormalities. Russian Medical Journal. 2001;10:427-30 (In Russ.).
7. Leite P.M., Martins M.A.P., Castilho R.O. Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy. Biomed Pharmacother. 2016;83:14-21. DOI:10.1016/j.biopha.2016.06.012.
8. Kropacheva E.S., Panchenko Е.P., Dobrovolsky A.В., Saidova M.A. Resistance to warfarin in a patient with absolute contraindications to use vitamin K antagonists. Atherothrombosis Journal. 2009;1(2):99-104 (In Russ.).
9. Tatsumi A., Kadobayashi M., Iwakawa S. Effect of ethanol on the binding of warfarin enantiomers to human serum albumin. Biol Pharm Bull. 2007;30(4):826-9. DOI:10.1248/bpb.30.826.
10. Fung E., Patsopoulos N.A., Belknap S.M., et al. Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin. Thromb Hemost. 2012;38(8):893-904. DOI:10.1055/s-0032-1328891.
11. Al-Arifi M.N., Wajid S., Al-Manie N.K., et al. Evaluation of knowledge of health care professionals on warfarin interactions with drug and herb medicinal in Central Saudi Arabia. Pak J Med Sci. 2016;2(1):229-233. DOI:10.12669/pjms.321.8902.
12. Instructions for use of the drug for medical use of Allochol [cited by Oct 08, 2019. Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=ba3f0e46-5098-46e4-933f172319b8ff7f&t=. (In Russ.).
13. Bielecki S., Dolim Lee D., Hamad B. The market for oral anticoagulants. Nature Reviews Drug Discovery. 2018;17:617-8. DOI:10.1038/nrd.2018.89.
14. Jaiswal P., Shinde S. Anticoagulants market-global opportunity analysis and industry forecast, 2018-2025. Allied Market Research. 2018. [cited by Oct 08, 2019]. Available from: https://www.alliedmarketresearch.com/anticoagulant-drugs-market .
15. Pirmohamed M. Warfarin: the end or the end of one size fits all therapy? J Pers Med. 2018;8(3):piiE22. DOI:10.3390/jpm8030022.
16. Skirdenko J.P., Nikolayev N.A. New Approaches to Individualized Choice of Oral Anticoagulants in Patients with Atrial Fibrillation. Rational Pharmacotherapy in Cardiology 2018;14(1):58-64 (In Russ.) DOI:10.20996/1819-6446-2018-14-1-58-64.
17. Martsevich S.Y., Lukina Y.V. Warfarin and its Importance in the Era of New Oral Anticoagulants. Issues of Monitoring the Effectiveness and Safety of Treatment. Rational Pharmacotherapy in Cardiology. 2017;13(5):699-705 (In Russ.). DOI:10.20996/1819-6446-2017-13-5-699-705.
18. Durães A.R., de Souza Lima Bitar Y., Filho J.A.L, et al. Rivaroxaban versus warfarin in patients with mechanical heart valve: rationale and design of the RIWA Study. Drugs R D. 2018;18(4):303-8. DOI:10.1007/s40268-018-0249-5.
19. Macan H., Uykimpang R., Alconcel M., et al. Aged garlic extract may be safe for patients on warfarin therapy. J Nutr. 2006;136(3 Suppl):793S-795S. DOI:10.1093/jn/136.3.793S.
20. Choi S., Oh D.S., Jerng U.M. A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. PLoS One. 2017;12(8):e0182794. DOI:10.1371/journal.pone.0182794.
21. Rahman K. Effects of garlic on platelet biochemistry and physiology. Mol Nutr Food Res. 2007;51(11):1335-44. DOI:10.1002/mnfr.200700058.
22. Mohammed Abdul M.I., Jiang X., Williams K.M., et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. 2008;154(8):1691-700. DOI:10.1038/bjp.2008.210.
23. Fasinu P.S., Bouic P.J., Rosenkranz B. An overview of the evidence and mechanisms of herbdrug interactions. Front Pharmacol. 2012;3:69. DOI:10.3389/fphar.2012.00069.
24. Lutomski J., Speichert H. Die Brennessel in Heilkunde und Ernährung. Pharmazie in unserer Zeit. 1983;12:181-6. DOI:10.1002/pauz.19830120602.
25. Biró-Sándor Z. Assessment report on Urtica Dioica L., and Urtica Urens L., herba. London: European Medicines Agency; 2008.
26. Dhouibi R., Affes H., Ben Salem M., et al. Screening of pharmacological uses of Urtica dioica and others benefits. Prog Biophys Mol Biol. 2020;150:67-77. DOI:10.1016/j.pbiomolbio.2019.05.008.
27. McDowell L.R. Vitamins in animal and human nutrition. 2nd Edition. New York: John Wiley & Sons; 2008.
Review
For citations:
Vatutin N.T., Taradin G.G., Ignatenko G.A., Gasendich E.S., Harchenko A.V., Povaljaeva I.B. Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report). Rational Pharmacotherapy in Cardiology. 2020;16(1):40-45. (In Russ.) https://doi.org/10.20996/1819-6446-2020-02-01
Views: 1035
Email this article 